Follicular development during the follicular phase of the menstrual cycle: the enigma of luteinizing hormone receptor function. [PDF]
Yding Andersen C +3 more
europepmc +1 more source
Cytologic Characteristics of the Feline Ovary at Different Sexual Stages
ABSTRACT Background Cytology is a valuable diagnostic tool in veterinary medicine, allowing rapid and minimally invasive diagnosis. However, its application in the reproductive tracts of small animals is limited, primarily used to assess mammary masses and stage the estrous cycle.
Alba Martí +4 more
wiley +1 more source
Reassessing the Luteinizing Hormone/Follicle-Stimulating Hormone Ratio in Polycystic Ovary Syndrome: Associations With a Possible Neuroendocrine and Anti-Müllerian Hormone-Related Phenotype. [PDF]
Yesiladali M +5 more
europepmc +1 more source
Abstract The aim of this study was to determine whether inflammatory and vascular responses to passive heating differ between the early follicular phase (EFP) and the mid‐luteal phase (MLP) of the menstrual cycle. Ten healthy, naturally menstruating females (26 ± 3 years of age; body mass index 21.4 ± 1.9 kg/m2) were assessed during EFP and MLP ...
Yunuo Su +3 more
wiley +1 more source
Transvaginal ultrasound combined with serum anti-Müllerian hormone, follicle-stimulating hormone, and luteinizing hormone in the evaluation of ovarian reserve function in infertile patients. [PDF]
Ying J, Hu X, Liu Z, Shi L, Li L.
europepmc +1 more source
Menopause and vascular endothelial health: Is it all about the oestrogen?
Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols +4 more
wiley +1 more source
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan +4 more
wiley +1 more source
Luteinizing hormone supplementation and cumulative live birth rate in assisted reproductive technology cycles among women of advanced reproductive age. [PDF]
Xia L +8 more
europepmc +1 more source
Abstract Women remain underrepresented in thermal physiology research, particularly within studies examining physiological adaptation to hot environments. Among the limited research that includes female participants, few studies have appropriately classified menstrual status of their participants or rigorously accounted for ovarian hormone influences ...
Jessica A. Mee, Tessa R. Flood
wiley +1 more source
Passive heat intervention research in women: Systematic review and audit of female representation
Abstract Passive heat interventions (PHIs) are non‐exercise heat‐acclimation strategies that improve physiological markers associated with heat tolerance and reduce vulnerability to heat‐related illness, when exercise is not feasible. However, representation of female participants within this literature remains unclear.
Jessica A. Mee +7 more
wiley +1 more source

